April 2026 – ubersmt, a U.S.-based electronics manufacturing services provider, has expanded its inspection capabilities with the purchase of a PARMI Xceed 3D automated optical inspection (AOI) system ...
Two years after AstraZeneca splashed out $1 billion upfront for rights to Daiichi Sankyo's TROP2-targeting antibody-drug conjugate DS-1062, the drug has generate promising results in advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results